ARCH 发表于 2025-3-25 06:02:52

Introduction to Nanomedicine,pplication of nanomedicine in diagnostics and therapy of a wide range of diseases such as cancer, cardiovascular, orthopaedics, and neurodegenerative disorders. A wide range of nanomaterials, nanoparticles and biomaterials for these applications are discussed.

triptans 发表于 2025-3-25 08:36:01

http://reply.papertrans.cn/67/6609/660835/660835_22.png

ITCH 发表于 2025-3-25 15:20:16

Nanomedicine for Neurodegenerative Diseases,r inhibiting the amyloid aggregation and tau hyperphosphorylation associated with the Alzheimer’s disease (AD). Different NP-based drug delivery approaches (e.g., apolipoprotein, peptides, dendrimers) to the delivery of CNS drugs across the blood–brain barrier (BBB) are discussed.

水土 发表于 2025-3-25 18:05:12

http://reply.papertrans.cn/67/6609/660835/660835_24.png

Entirety 发表于 2025-3-25 21:19:02

Nanomedicine for Cardiac Diseases,s and devices to diagnose, treat, and prevent a variety of cardiovascular diseases. The development of nanocarriers for drug delivery is a key application of nanomedicine in cardiology. This chapter delineates the applications of nanomedicine in diagnostics and treatment of cardiovascular diseases.

转向 发表于 2025-3-26 03:18:35

http://reply.papertrans.cn/67/6609/660835/660835_26.png

实现 发表于 2025-3-26 06:59:44

Cancer Nanomedicine,-, graphene-, graphene oxide- based nanocarriers, peptides or polymer mediated delivery vehicles, and liposomes for targeted delivery are discussed. Metallic nanostructures and plasmonic bimetallic nanocrystals and core–shell nanocomposites for combined photothermal-/chemo- or radio-/chemo-therapy are delineated.

Cholecystokinin 发表于 2025-3-26 12:24:37

http://reply.papertrans.cn/67/6609/660835/660835_28.png

小样他闲聊 发表于 2025-3-26 15:19:45

http://reply.papertrans.cn/67/6609/660835/660835_29.png

JOT 发表于 2025-3-26 17:01:33

http://reply.papertrans.cn/67/6609/660835/660835_30.png
页: 1 2 [3] 4 5
查看完整版本: Titlebook: Nanomedicine; Emerging Prospects Subramanian Tamil Selvan Book 2023 The Editor(s) (if applicable) and The Author(s), under exclusive licens